+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neoadjuvant intravenous cisplatin for T2-4NxMo bladder cancer



Neoadjuvant intravenous cisplatin for T2-4NxMo bladder cancer



Progress in Clinical and Biological Research 260: 561-570




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040779980

Download citation: RISBibTeXText

PMID: 3362905


Related references

Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy. Journal of Experimental and Clinical Cancer Research 35: 2, 2016

Relative efficacy of neoadjuvant gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management for muscle-invasive bladder cancer. Hinyokika Kiyo. Acta Urologica Japonica 59(5): 277-281, 2013

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer. Cancer 121(15): 2586-2593, 2015

Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer. Advances in Urology 2013: 317190, 2013

Neoadjuvant cisplatin for advanced bladder cancer. Cochrane Database of Systematic Reviews (): Cd001426-Cd001426, 2000

What are the Facilitators and Obstacles to Participation in Workplace Team Sport? A Qualitative Study. Aims Public Health 4(1): 94, 2017

Bladder cancer - neoadjuvant therapy with cisplatin and gemcitabine. Aktuelle Urologie 44(5): 340-342, 2014

Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced bladder cancer overview collaboration. Journal of Urology 154(5): 1970, 1995

Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer. Japanese Journal of Clinical Oncology 41(7): 908-914, 2011

Cisplatin-based neoadjuvant chemotherapy for invasive bladder cancer. Hiroshima Journal of Medical Sciences 44(4): 129-132, 1995

Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder. Cancer 118(1): 72-81, 2012

Neoadjuvant chemotherapy using methotrexate and cisplatin in locally advanced urothelial cancer of the bladder. Archivio Italiano di Urologia Nefrologia Andrologia 62(2): 231-235, 1990

Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer. Cancer Research and Treatment 48(3): 1084-1091, 2016

An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer. Biomolecules 6(3):, 2016

Neoadjuvant medium-dose methotrexate, cisplatin in category T3b-T4a (N0M0) bladder cancer. Progress in Clinical and Biological Research 353: 129-136, 1990